Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 55 articles:
HTML format



Single Articles


    February 2024
  1. SHAH ED
    Concise Commentary: Red Mucosa Is Not Enough-Another Approach to Treating Dyspeptic Symptoms.
    Dig Dis Sci. 2024;69:320-321.
    PubMed    


  2. ZUZEK R, Potter M, Talley NJ, Agreus L, et al
    Prevalence of Histological Gastritis in a Community Population and Association with Epigastric Pain.
    Dig Dis Sci. 2024;69:528-537.
    PubMed     Abstract available


    November 2023
  3. LOW EXS, Wang YP, Lu CL
    Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08153.
    PubMed     Abstract available


    October 2023
  4. NAKANO T, Dohi O, Takagi T, Naito Y, et al
    Characteristics of Gastric Mucosa-Associated Microbiota in Patients with Early Gastric Cancer After Successful Helicobacter pylori Eradication.
    Dig Dis Sci. 2023 Oct 24. doi: 10.1007/s10620-023-08154.
    PubMed     Abstract available


  5. KAUR P, Verma N, Valsan A, Garg P, et al
    Prevalence, Risk Factors, and Impact of Bacterial or Fungal Infections in Acute Liver Failure Patients from India.
    Dig Dis Sci. 2023;68:4022-4038.
    PubMed     Abstract available


    September 2023
  6. FRANKO J
    Removing the Appendix: Prologue to Severe Clostridioides difficile Infection and Recurrence?
    Dig Dis Sci. 2023;68:3488-3489.
    PubMed    


  7. NAGA YSE, Dhindsa BS, Bapaye J, Tun KM, et al
    A Systematic Review and Meta-Analysis: A Prior Appendectomy Does Not Increase the Risk of Severe Clostridioides difficile Infection or Recurrence.
    Dig Dis Sci. 2023;68:3714-3720.
    PubMed     Abstract available


    August 2023
  8. BRZEZINSKA K, Tikh E, Jangi S, Chen HH, et al
    Surprising Diagnosis of a Case with Disseminated Tuberculosis Masquerading as Metastatic Cancer.
    Dig Dis Sci. 2023 Aug 24. doi: 10.1007/s10620-023-08083.
    PubMed    


  9. SIDDIQUE DA, Jansson-Knodell CL, Gupta A, Howard G, et al
    Clinical Presentation of Small Intestinal Bacterial Overgrowth from Aerodigestive Tract Bacteria Versus Colonic-Type Bacteria: A Comparison Study.
    Dig Dis Sci. 2023;68:3390-3399.
    PubMed     Abstract available


    June 2023
  10. GENUA F, Butt J, Waterboer T, Hughes DJ, et al
    Association of Antibody Responses to Fusobacterium nucleatum and Streptococcus gallolyticus Proteins with Colorectal Adenoma and Colorectal Cancer.
    Dig Dis Sci. 2023 Jun 20. doi: 10.1007/s10620-023-08001.
    PubMed     Abstract available


  11. WERNLY S, Paar V, Volkerer A, Semmler G, et al
    sST2 Levels Show No Association with Helicobacter pylori Infection in Asymptomatic Patients: Implications for Biomarker Research.
    Dig Dis Sci. 2023 Jun 20. doi: 10.1007/s10620-023-08005.
    PubMed     Abstract available


  12. MANGIPUDI UK, Kundu R, Ramachandran R, Gupta R, et al
    Mediastinal Histoplasmosis Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Biopsy.
    Dig Dis Sci. 2023;68:2204-2206.
    PubMed    


    May 2023
  13. SANDHU S, John BV
    Spontaneous Bacterial Peritonitis: The Bug Matters.
    Dig Dis Sci. 2023;68:1667-1669.
    PubMed    


  14. FUREY C, Zhou S, Park JH, Foong A, et al
    Impact of Bacteria Types on the Clinical Outcomes of Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2023;68:2140-2148.
    PubMed     Abstract available


  15. WEINGARDEN AR, Treiger O, Ulsh L, Limketkai B, et al
    Delivery of Fecal Material to Terminal Ileum Is Associated with Long-Term Success of Fecal Microbiota Transplantation.
    Dig Dis Sci. 2023;68:2006-2014.
    PubMed     Abstract available


    April 2023
  16. NIROOMAND E, Kumar SR, Goldberg D, Kumar S, et al
    Impact of Medicaid Expansion on Incidence and Mortality from Gastric and Esophageal Cancer.
    Dig Dis Sci. 2023;68:1178-1186.
    PubMed     Abstract available


    March 2023
  17. TAN MC, Mallepally N, Nguyen TH, Hammad T, et al
    Missed Opportunities for Screening or Surveillance Among Patients with Newly Diagnosed Non-cardia Gastric Adenocarcinoma.
    Dig Dis Sci. 2023;68:761-769.
    PubMed     Abstract available


  18. GRAHAM DY
    Why the Vonoprazan Helicobacter pylori Therapies in the US-European Trial Produced Unacceptable Cure Rates.
    Dig Dis Sci. 2023 Mar 1. doi: 10.1007/s10620-023-07886.
    PubMed     Abstract available


    December 2022
  19. KOWADA A
    A Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening.
    Dig Dis Sci. 2022 Dec 24. doi: 10.1007/s10620-022-07795.
    PubMed     Abstract available


    October 2022
  20. SUCHMAN K, Luo Y, Grinspan A
    Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort.
    Dig Dis Sci. 2022;67:4866-4873.
    PubMed     Abstract available


    September 2022
  21. KLIGMAN E, Ali H, Chen E, Peng F, et al
    Ethnicity Is an Important Consideration in Screening for Gastric Intestinal Metaplasia.
    Dig Dis Sci. 2022;67:4509-4517.
    PubMed     Abstract available


  22. TAN MC, Ho Q, Nguyen TH, Liu Y, et al
    Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population.
    Dig Dis Sci. 2022;67:4500-4508.
    PubMed     Abstract available


    August 2022
  23. MENG Y, Li Y, Hao R, Li X, et al
    Correction: Analysis of Phenotypic Variables and Differentiation Between Untypical Crohn's Disease and Untypical Intestinal Tuberculosis.
    Dig Dis Sci. 2022 Aug 22. pii: 10.1007/s10620-022-07647.
    PubMed    


  24. LI Y, Cai H, Sussman DA, Donet J, et al
    Association Between Immunosuppressive Therapy and Outcome of Clostridioides difficile Infection: Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022;67:3890-3903.
    PubMed     Abstract available


    July 2022
  25. FEUERSTADT P, Aroniadis OC, Svedlund FL, Garcia M, et al
    Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection.
    Dig Dis Sci. 2022;67:2763-2770.
    PubMed     Abstract available


    June 2022
  26. MENDELSOHN RB, Kaltsas A, King S, Hwang C, et al
    Fecal Microbiota Transplantation Is Safe for Clostridiodies difficile Infection in Patients with Solid Tumors Undergoing Chemotherapy.
    Dig Dis Sci. 2022;67:2503-2509.
    PubMed     Abstract available


  27. LEE JS, Jeon SW, Lee HS, Kwon YH, et al
    Rebamipide for the Improvement of Gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Pilot Study.
    Dig Dis Sci. 2022;67:2395-2402.
    PubMed     Abstract available


    May 2022
  28. OKAGAWA Y, Abe S, Yamada M, Oda I, et al
    Artificial Intelligence in Endoscopy.
    Dig Dis Sci. 2022;67:1553-1572.
    PubMed     Abstract available


    April 2022
  29. B HADI Y, Khan RS, Lakhani DA, Khan AY, et al
    Antibiotic Prophylaxis for Upper Gastrointestinal Bleed in Liver Cirrhosis; Less May Be More.
    Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07481.
    PubMed     Abstract available


  30. JEONG JH, Lee SY, Kim JH, Sung IK, et al
    Useful Serum Pepsinogen Levels for Detecting Ongoing Helicobacter pylori Infection in Asymptomatic Subjects: A Cross-Sectional Study Based on (13)C-urea Breath Test Findings.
    Dig Dis Sci. 2022 Apr 6. pii: 10.1007/s10620-022-07471.
    PubMed     Abstract available


    March 2022
  31. TIXIER EN, Verheyen E, Luo Y, Grinspan LT, et al
    Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
    Dig Dis Sci. 2022;67:978-988.
    PubMed     Abstract available


    February 2022
  32. SHAH SC, Tarassishin L, Eisele C, Rendon A, et al
    Breastfeeding Is Associated with Lower Likelihood of Helicobacter Pylori Colonization in Babies, Based on a Prospective USA Maternal-Infant Cohort.
    Dig Dis Sci. 2022 Feb 4. pii: 10.1007/s10620-021-07371.
    PubMed     Abstract available


    January 2022
  33. SHAH SC, Bonnet K, Schulte R, Peek RM Jr, et al
    Helicobacter pylori Management Is Associated with Predominantly Negative Patient Experiences: Results from a Focused Qualitative Analysis.
    Dig Dis Sci. 2022 Jan 16. pii: 10.1007/s10620-021-07320.
    PubMed     Abstract available


  34. FILIK L
    C. difficile in COVID-19 Patients: Is It a Colonization Issue?
    Dig Dis Sci. 2022;67:350.
    PubMed    


    December 2021
  35. HOWDEN CW, Sheldon KL, Almenoff JS, Chey WD, et al
    Pitfalls of Physician-Directed Treatment of Helicobacter pylori: Results from Two Phase 3 Clinical Trials and Real-World Prescribing Data.
    Dig Dis Sci. 2021 Dec 4. pii: 10.1007/s10620-021-07323.
    PubMed     Abstract available


  36. LASZKOWSKA M, Kim J, Faye AS, Joelson AM, et al
    Prevalence of Clostridioides difficile and Other Gastrointestinal Pathogens in Patients with COVID-19.
    Dig Dis Sci. 2021;66:4398-4405.
    PubMed     Abstract available


    November 2021
  37. LU L, Fan J, Xu W, Cui X, et al
    DNA Methylome Mapping Identifies Epigenetic Abnormalities in Intestinal Lymphocyte Regulation in Human Necrotizing Enterocolitis.
    Dig Dis Sci. 2021 Nov 30. pii: 10.1007/s10620-021-07314.
    PubMed     Abstract available


  38. BAIU I, Forgo E, Kin C, Weiser TG, et al
    Cec and You Shall Find: Cecal Perforation in a Patient with COVID-19.
    Dig Dis Sci. 2021;66:3731-3734.
    PubMed    


  39. ABDU B, Akolkar S, Picking C, Boura J, et al
    Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2021;66:4035-4045.
    PubMed     Abstract available


    October 2021
  40. SPRAGUE R, Warny K, Pollock N, Daugherty K, et al
    Absence of Toxemia in Clostridioides difficile Infection: Results from Ultrasensitive Toxin Assay of Serum.
    Dig Dis Sci. 2021;66:3303-3306.
    PubMed     Abstract available


    September 2021
  41. HSU D, Martin B, Forgo E, Greene E, et al
    Tough to Swallow: Dysphagia in a Child with an Aberrant Left Subclavian Artery.
    Dig Dis Sci. 2021;66:2882-2887.
    PubMed    


  42. VARMA S, Faye AS, Kannan A, Lawlor G, et al
    Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
    Dig Dis Sci. 2021;66:3113-3123.
    PubMed     Abstract available


    August 2021
  43. ESAKI M, Minoda Y, Ihara E
    In Living Color: Linked Color Imaging for the Detection of Early Gastric Cancer.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07235.
    PubMed    


  44. ISHIDA T, Dohi O, Yoshida N, Yasuda T, et al
    Enhanced Visibility in Evaluating Gastric Cancer and Helicobacter pylori-Associated Gastritis Using Linked Color Imaging with a Light-Emitting Diode Light Source.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07234.
    PubMed     Abstract available


  45. HWANG YJ, Choi Y, Kim N, Lee HS, et al
    The Difference of Endoscopic and Histologic Improvements of Atrophic Gastritis and Intestinal Metaplasia After Helicobacter pylori Eradication.
    Dig Dis Sci. 2021 Aug 7. pii: 10.1007/s10620-021-07146.
    PubMed     Abstract available


    May 2021
  46. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
    Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
    Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
    PubMed     Abstract available


  47. SAKAE H, Kanzaki H, Satomi T, Okanoue S, et al
    Linked Color Imaging (LCI) Emphasizes the Color Changes in the Gastric Mucosa After Helicobacter pylori Eradication.
    Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07030.
    PubMed     Abstract available


    April 2021
  48. KUMAR S, Goldberg DS, Kaplan DE
    Ranitidine Use and Gastric Cancer Among Persons with Helicobacter pylori.
    Dig Dis Sci. 2021 Apr 15. pii: 10.1007/s10620-021-06972.
    PubMed     Abstract available


    March 2021
  49. CHANG YW, Shin GY, Kim JW, Moon JC, et al
    Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication.
    Dig Dis Sci. 2021 Mar 23. pii: 10.1007/s10620-021-06938.
    PubMed     Abstract available


    February 2021
  50. HE XJ, Zeng XP, Jiang CS, Liu G, et al
    Efficacy and Safety of Antofloxacin-Based Triple Therapy for Helicobacter pylori Eradication Failure in China.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06856.
    PubMed     Abstract available


  51. WEITSMAN S, Celly S, Leite G, Mathur R, et al
    Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes.
    Dig Dis Sci. 2021 Feb 3. pii: 10.1007/s10620-021-06857.
    PubMed     Abstract available


    January 2021
  52. DEL VALLE JP, Lee GC, Serrato JC, Feuerstein JD, et al
    Recurrence of Clostridium Difficile and Cytomegalovirus Infections in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-Anal Anastomosis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06772.
    PubMed     Abstract available


  53. KOWADA A
    Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
    Dig Dis Sci. 2021 Jan 8. pii: 10.1007/s10620-020-06813.
    PubMed     Abstract available


    November 2020
  54. JIN A, Chien T, Huang Q, Kenkare P, et al
    History of Cholecystectomy and Risk of Clostridium Difficile Infection.
    Dig Dis Sci. 2020 Nov 25. pii: 10.1007/s10620-020-06714.
    PubMed     Abstract available


    September 2020
  55. SMITH R, Hubers J, Farraye FA, Sampene E, et al
    Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 29. pii: 10.1007/s10620-020-06631.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.